Developer docs
API playgroundTry for free, no card

Search company profiles

Calvert Labs

Full company profile

uuid000mltf

Namestring
Calvert Labs
Legal namestring
Altasciences
Websiteurl
calvertlabs.com
Company typeenum
Private
Founded yearint
1969
Descriptiontext

Calvert Labs is a privately held, for-profit contract research organization headquartered in Cary, North Carolina, founded in 1969. The firm specializes in preclinical research services for the biopharmaceutical industry, with an offering centered on lead identification, lead optimization, and preclinical safety and efficacy evaluation. According to the firmographic record, the company operates with a headcount in the 51-100 range, positioning it as a small-to-mid preclinical CRO relative to larger, multi-service competitors.

The firm's service portfolio spans early-phase drug development activities, including GLP and non-GLP preclinical studies, bioanalytical support, and research services that bridge into early clinical phases. A chief scientific officer (Charles Spainhour, CSO & EVP) anchors scientific leadership. The aggregated source dataset also describes broader operational and commercial attributes — including multi-site presence across the United States and Canada, an integrated Acceleration Platform designed to reduce program durations, direct sales-led go-to-market targeting biopharmaceutical sponsors, and a 2026 industry recognition as Best Biopharmaceutical CRO by GHP — though these signals appear in a wider CRO context and should be interpreted cautiously with respect to Calvert Labs specifically.

The business model is professional services-based: revenue is generated through custom contract engagements with biopharmaceutical sponsors, priced on a per-project basis reflecting scope, duration, and complexity. Pricing is not publicly disclosed. Calvert Labs serves biopharmaceutical companies of varying sizes seeking preclinical research support, with a horizontal segmentation approach targeting the broader industry rather than a narrow therapeutic vertical. Distribution is primarily direct via field-based business development and scientific account managers.

Short descriptiontext

Calvert Labs is a privately held US-based contract research organization founded in 1969 in Cary, North Carolina, providing preclinical, lead identification, and lead optimization services to biopharmaceutical sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCary, United States
HQ citystring
Cary
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research services, preclinical safety testing, lead optimization services, clinical pharmacology trials, bioanalytical laboratory services
Industry2 codes
PRIMARYHLAGAFAB
Safety Pharmacology (Cardio/CNS/Respiratory)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services - Preclinical Drug Development
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

Revenue generated from providing preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis, research services, and manufacturing and analytical services to biopharmaceutical companies. Services can be packaged or provided as stand-alone offerings.

altasciences.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Calvert Labs is a contract research organization offering a wide range of lead identification, lead optimization, and preclinical services to biopharmaceutical companies. The organization provides integrated preclinical safety testing for small and large molecules, clinical pharmacology trials from first-in-human through Phase II, bioanalytical laboratory services spanning preclinical through Phase IV, formulation development and analytical services, and research support services. Services can be delivered as standalone offerings or packaged together through an integrated Acceleration Platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduce program durations by up to 40%
+1 more record
Product overview1 text field

Altasciences is a forward-thinking, mid-size early phase contract research organization (CRO) offering a unified platform approach to drug development. The company operates as a single CRO/CDMO partner providing integrated preclinical services (safety assessments for small and large molecules), clinical services (Phase I to Phase II), bioanalytical services (preclinical to Phase IV), manufacturing and analytical services (formulation development through commercial manufacturing), research support services, and customizable Development Programs. The Acceleration Platform ties these services together to deliver seamless drug development from lead candidate selection to proof of concept, with demonstrated ability to reduce program durations by up to 40%.

Product and service1 record
1Preclinical Services
CategoryPreclinical Research Services
Description

Safety assessments for both small and large molecules, including GLP and non-GLP preclinical evaluation studies in multiple species for biopharmaceutical sponsors.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO with the largest preclinical and safety assessment franchise, including Safety Pharmacology and DMPK services that directly overlap Calvert Labs' core offering across multiple sites.

TypeBroad incumbent
Description

Diversified CRO offering preclinical safety, bioanalytical, and clinical services; competes with Calvert Labs for outsourced lead optimization and IND-enabling toxicology work.

TypeDirect peer
Description

Mid-size preclinical and bioanalytical CRO with integrated safety, DMPK, and CMC services; closely mirrors Calvert Labs' position as a specialized preclinical partner for biopharma.

TypeDirect peer
Description

Preclinical CRO and contract research services provider focused on toxicology, safety, and discovery services for pharma and medical device clients; competes in the same preclinical niche as Calvert Labs.

TypeDirect peer
Description

Early-phase clinical pharmacology and bioanalytical CRO with preclinical service overlap, providing similar integrated lead optimization support to small and mid-sized biopharma sponsors.

TypeBroad incumbent
Description

Global CRO/CDMO with preclinical safety, DMPK, and bioanalytical services; competes for outsourced preclinical programs with cost-competitive offerings, particularly from China-based operations.

TypeBroad incumbent
Description

Large integrated CRO/CDMO with extensive preclinical safety and DMPK capacity; competes on scale and global reach for outsourced preclinical study programs.

TypeDirect peer
Description

European-headquartered early-phase CRO offering preclinical and clinical pharmacology services to biopharma; comparable mid-size competitor focused on early drug development.

TypeBroad incumbent
Description

Global CRO with preclinical and laboratory services divisions, including bioanalytical and safety assessment capabilities that overlap with Calvert Labs' preclinical scope.

TypeEmerging player
Description

Discovery and preclinical services arm of Eurofins Scientific, offering in vitro and in vivo pharmacology, safety, and DMPK services; adjacent competitor in outsourced preclinical research.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Calvert Labs

Contract Research Organization (CRO) Services - Preclinical Drug Developmentcalvertlabs.com

Calvert Labs is a privately held US-based contract research organization founded in 1969 in Cary, North Carolina, providing preclinical, lead identification, and lead optimization services to biopharmaceutical sponsors.

What Calvert Labs does

Calvert Labs is a privately held, for-profit contract research organization headquartered in Cary, North Carolina, founded in 1969. The firm specializes in preclinical research services for the biopharmaceutical industry, with an offering centered on lead identification, lead optimization, and preclinical safety and efficacy evaluation. According to the firmographic record, the company operates with a headcount in the 51-100 range, positioning it as a small-to-mid preclinical CRO relative to larger, multi-service competitors.

The firm's service portfolio spans early-phase drug development activities, including GLP and non-GLP preclinical studies, bioanalytical support, and research services that bridge into early clinical phases. A chief scientific officer (Charles Spainhour, CSO & EVP) anchors scientific leadership. The aggregated source dataset also describes broader operational and commercial attributes — including multi-site presence across the United States and Canada, an integrated Acceleration Platform designed to reduce program durations, direct sales-led go-to-market targeting biopharmaceutical sponsors, and a 2026 industry recognition as Best Biopharmaceutical CRO by GHP — though these signals appear in a wider CRO context and should be interpreted cautiously with respect to Calvert Labs specifically.

The business model is professional services-based: revenue is generated through custom contract engagements with biopharmaceutical sponsors, priced on a per-project basis reflecting scope, duration, and complexity. Pricing is not publicly disclosed. Calvert Labs serves biopharmaceutical companies of varying sizes seeking preclinical research support, with a horizontal segmentation approach targeting the broader industry rather than a narrow therapeutic vertical. Distribution is primarily direct via field-based business development and scientific account managers.

Calvert Labs firmographics

Firmographics
Name
Calvert Labs
Legal name
Altasciences
Website
https://calvertlabs.com
Company type
Private
Founded year
1969
Operating status
Operating
Headcount range
51–100 employees
Short description
Calvert Labs is a privately held US-based contract research organization founded in 1969 in Cary, North Carolina, providing preclinical, lead identification, and lead optimization services to biopharmaceutical sponsors.
Ownership category
akta.pro rank

Calvert Labs industry classification

Industry
Product category
Contract Research Organization (CRO) Services - Preclinical Drug Development
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAFAB
Safety Pharmacology (Cardio/CNS/Respiratory)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Contract research services
  • Preclinical safety testing
  • Lead optimization services
  • Clinical pharmacology trials
  • Bioanalytical laboratory services

Where Calvert Labs is headquartered

Location

Headquarters

HQ city
Cary
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Calvert Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: Revenue generated from providing preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis, research services, and manufacturing and analytical services to biopharmaceutical companies. Services can be packaged or provided as stand-alone offerings.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Calvert Labs product offering

Product offering

Core offering

Calvert Labs is a contract research organization offering a wide range of lead identification, lead optimization, and preclinical services to biopharmaceutical companies. The organization provides integrated preclinical safety testing for small and large molecules, clinical pharmacology trials from first-in-human through Phase II, bioanalytical laboratory services spanning preclinical through Phase IV, formulation development and analytical services, and research support services. Services can be delivered as standalone offerings or packaged together through an integrated Acceleration Platform.

Product overview

Altasciences is a forward-thinking, mid-size early phase contract research organization (CRO) offering a unified platform approach to drug development. The company operates as a single CRO/CDMO partner providing integrated preclinical services (safety assessments for small and large molecules), clinical services (Phase I to Phase II), bioanalytical services (preclinical to Phase IV), manufacturing and analytical services (formulation development through commercial manufacturing), research support services, and customizable Development Programs. The Acceleration Platform ties these services together to deliver seamless drug development from lead candidate selection to proof of concept, with demonstrated ability to reduce program durations by up to 40%.

Differentiator

Problem solved

Functional benefit

Products and services

  • Preclinical Services Safety assessments for both small and large molecules, including GLP and non-GLP preclinical evaluation studies in multiple species for biopharmaceutical sponsors.

Quantifiable outcome

  • Reduce program durations by up to 40%
  • +1 more outcomes

Companies that use Calvert Labs

Customer profile

Named customers6 records

Segments1 record

Ideal customer profiles1 record

Calvert Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Calvert Labs partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Calvert Labs competitors and assessment

Company assessment

Broad incumbents

  • Charles River Laboratories: Global CRO with the largest preclinical and safety assessment franchise, including Safety Pharmacology and DMPK services that directly overlap Calvert Labs' core offering across multiple sites.
  • Labcorp Drug Development (Covance): Diversified CRO offering preclinical safety, bioanalytical, and clinical services; competes with Calvert Labs for outsourced lead optimization and IND-enabling toxicology work.
  • Pharmaron: Global CRO/CDMO with preclinical safety, DMPK, and bioanalytical services; competes for outsourced preclinical programs with cost-competitive offerings, particularly from China-based operations.
  • Wuxi AppTec: Large integrated CRO/CDMO with extensive preclinical safety and DMPK capacity; competes on scale and global reach for outsourced preclinical study programs.
  • ICON plc: Global CRO with preclinical and laboratory services divisions, including bioanalytical and safety assessment capabilities that overlap with Calvert Labs' preclinical scope.

Direct peers

  • Frontage Laboratories: Mid-size preclinical and bioanalytical CRO with integrated safety, DMPK, and CMC services; closely mirrors Calvert Labs' position as a specialized preclinical partner for biopharma.
  • Inotiv: Preclinical CRO and contract research services provider focused on toxicology, safety, and discovery services for pharma and medical device clients; competes in the same preclinical niche as Calvert Labs.
  • Celerion: Early-phase clinical pharmacology and bioanalytical CRO with preclinical service overlap, providing similar integrated lead optimization support to small and mid-sized biopharma sponsors.
  • Biotrial: European-headquartered early-phase CRO offering preclinical and clinical pharmacology services to biopharma; comparable mid-size competitor focused on early drug development.

Emerging players

  • Eurofins Discovery: Discovery and preclinical services arm of Eurofins Scientific, offering in vitro and in vivo pharmacology, safety, and DMPK services; adjacent competitor in outsourced preclinical research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Calvert Labs social profiles

Digital presence

Calvert Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calvert Labs leadership team

Management profile

Number of profiles

Profiles1 record

Calvert Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calvert Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calvert Labs

What does Calvert Labs do?

Calvert Labs is a contract research organization offering a wide range of lead identification, lead optimization, and preclinical services to biopharmaceutical companies. The organization provides integrated preclinical safety testing for small and large molecules, clinical pharmacology trials from first-in-human through Phase II, bioanalytical laboratory services spanning preclinical through Phase IV, formulation development and analytical services, and research support services. Services can be delivered as standalone offerings or packaged together through an integrated Acceleration Platform.

When was Calvert Labs founded?

Calvert Labs was founded in 1969. It employs 51 to 100 people.

Where is Calvert Labs based?

Calvert Labs is headquartered in Cary, United States, in the North America region.

How does Calvert Labs make money?

One revenue line is on record: contract Research Services.

Who are Calvert Labs's main competitors?

Broad incumbents on record are Charles River Laboratories, Labcorp Drug Development (Covance), Pharmaron, Wuxi AppTec and ICON plc. Direct peers are Frontage Laboratories, Inotiv, Celerion and Biotrial. Eurofins Discovery is listed as an emerging player.

Does Calvert Labs have an API?

No public API is recorded for Calvert Labs.

What industry is Calvert Labs in?

Calvert Labs's product category is Contract Research Organization (CRO) Services - Preclinical Drug Development. Its primary akta.pro industry code is HLAGAFAB, Safety Pharmacology (Cardio/CNS/Respiratory), with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Endpoints NewsAl­ta­sciences, true to its word, ex­pands its foot­print with ac­qui­si­tion of Penn­syl­va­nia CROAlta Sciences announced the acquisition of Calvert Laboratories, a preclinical CRO based in Pennsylvania. The Canadian CDMO, with roots in Seattle, is expanding its footprint to the east coast.BioSpaceAltasciences Acquires Calvert LaboratoriesAltasciences has completed the acquisition of Calvert Laboratories, a preclinical CRO located on the U.S.A.'s East Coast. The acquisition aims to enhance Altasciences' expertise in small molecule and preclinical services, expanding its presence and capabilities in drug development.PR NewswireNanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And TreatmentsNanoViricides has engaged Calvert Labs to conduct Safety Pharmacology studies for its COVID-19 drug candidate, with data intended for an IND application filing and pre-IND guidance from the FDA. Multiple biotech companies reported COVID-19 developments, including Pfizer and BioNTech's vaccine candidate demonstrating over 90% efficacy in Phase 3 interim analysis, Eli Lilly receiving FDA Emergency Use Authorization for its neutralizing antibody bamlanivimab, and Altimmune entering a manufacturing agreement with Lonza for its intranasal vaccine candidate AdCOVID. Researchers cited in the article argue that nanotechnology-based approaches could provide faster alternatives for COVID-19 diagnosis, treatment, and prevention compared to conventional methods.